
Sign up to save your podcasts
Or


Robin Feldman of the University of California Hastings College of Law and author of Drug Wars talks about her book with EconTalk host Russ Roberts. Feldman explores the various ways that pharmaceutical companies try to reduce competition from generic drugs. The conversation includes a discussion of the Hatch-Waxman Act and the sometimes crazy world of patent protection.
By Russ Roberts4.7
42164,216 ratings
Robin Feldman of the University of California Hastings College of Law and author of Drug Wars talks about her book with EconTalk host Russ Roberts. Feldman explores the various ways that pharmaceutical companies try to reduce competition from generic drugs. The conversation includes a discussion of the Hatch-Waxman Act and the sometimes crazy world of patent protection.

2,454 Listeners

2,270 Listeners

1,826 Listeners

1,516 Listeners

79 Listeners

990 Listeners

487 Listeners

22 Listeners

6,617 Listeners

549 Listeners

131 Listeners

2,035 Listeners

31 Listeners

738 Listeners

3,366 Listeners

715 Listeners

814 Listeners

8,454 Listeners

447 Listeners

146 Listeners

1,109 Listeners